Nina Li

About Nina Li

Biomedical engineer turned strategic advisor, I bring two decades of experience at the intersection of medtech innovation and capital strategy. My work spans from early R&D at Medtronic to cross-border M&A design at Morgan Stanley, and now as a Strategic Partner at CalmWave, where I help align AI-driven ICU solutions with real-world patient care needs. With a strong foundation in both engineering and finance (UC Berkeley, MIT Harvard HST, Booth Chicago), I specialize in translating complex technology into scalable clinical models. My focus is on structural value creation from reimbursement modeling to international market entry always guided by one principle: technology must serve human healing.

Experience

1. Strategic Partner & Venture Analyst Lead

   Calmwave

   Jan 2022 — Present · Seattle, WA, US

   Serving as a strategic partner at CalmWave, an AI-driven platform focused on ICU alarm fatigue management and clinical workflow optimization. Leading cross-functional strategy between medical device integration, patient signal intelligence, and venture pipeline development.Established CalmWave’s internal investment evaluation team, identifying synergistic partnerships in digital health, bio-interactive systems, and predictive diagnostics. Collaborate with clinicians, engineers, and investors to bridge patient-centered design with capital efficiency.My role combines hands-on clinical insight, financial modeling, and early stage technology due diligence positioned at the convergence of healthcare innovation and structured capital deployment.

Education

• Harvard–MIT Division of Health Sciences and Technology (HST)

  Master of Science

  1997 — 2000

• Northwestern University

  Bachelor of Science - BS

  1993 — 1997